Business Wire

Adtran accelerates broadband rollouts with market’s most scalable fiber access platform

24.1.2023 18:12:00 EET | Business Wire | Press release

Share

Adtran®, Inc., (NASDAQ:ADTN), the leading provider of next-generation open and disaggregated networking solutions, today launched its SDX 6330 10Gbit/s Combo PON fiber access platform, enabling service providers to rapidly and cost-effectively connect homes and businesses with fiber-based broadband. The new open and disaggregated solution offers the industry’s highest port density and is the first optical line terminal (OLT) with integrated 400Gbit/s uplinks. It will empower operators to accelerate fiber rollout and easily scale their networks to support dense urban, suburban and rural deployments. With enhanced energy efficiency, the highly compact, temperature-hardened fiber access platform will be important to meeting sustainability targets and addressing market demands for both retail and wholesale providers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230124005747/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Adtran’s SDX 6330 will help service providers meet subscriber demand in the most scalable and sustainable way possible. (Photo: Business Wire)

“Service providers face a tough environment as they strive to keep up with growing subscriber needs, expand coverage and meet green targets. With households and businesses accessing more and more data-hungry applications, operators need strategies in place to handle the surge in a cost-effective and sustainable way. This challenge is precisely what our third-generation fiber access platform aims to address,” said Robert Conger, SVP of technology and strategy at Adtran. “Our SDX 6330 offers the network simplicity, sustainability and scalability needed to power the Gigabit Society. That’s what makes it a compelling alternative to chassis-based architectures. It’s the solution many operators are searching for as they look to expand their market share while improving customer experience.”

The SDX 6330 is Adtran’s third generation of open and disaggregated OLT devices. With 48 ports of Combo PON in a compact and power-efficient design, it sets a new benchmark for lowering the total cost of deployment for 10Gbit/s services. Designed to deliver network simplicity and sustainability at scale, the solution offers deployment versatility and improved reach. Featuring open interfaces, it provides freedom to build best-in-class infrastructure with technology from multiple vendors, and its versatile architecture supports a wide range of network topologies and coherent optics. The SDX 6330 also helps meet corporate sustainability objectives by reducing power demand and landfill requirements.

“Our SDX 6330 is the most advanced fiber access platform in the industry, and the impact it’s about to have will be significant. By empowering service providers to reduce both the time and cost of getting people connected, we’re going to see broadband coverage increase like never before,” commented Ronan Kelly, CTO for EMEA and APAC at Adtran. “As pioneers in open and disaggregated fiber access innovation, we’ve consistently pushed boundaries, beginning with our industry-first deployments dating back to 2017. Now with our third-generation device, we’re taking density and scalability to new heights. Our SDX 6330 will transform networks into flexible, multigigabit service delivery platforms, empowering operators to stay ahead of the bandwidth consumption curve.”

About Adtran

Adtran, Inc. is a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. Adtran, Inc. is a wholly-owned subsidiary of ADTRAN Holdings, Inc. (NASDAQ:ADTN and FSE: QH9). Find more at Adtran, LinkedIn and Twitter.

Published by
Adtran, Inc.
www.adtran.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For media
Gareth Spence
t +44 1904 699 358
public-relations@adva.com

For investors
Rhonda Lambert
t +1 256-963-7450
investor@adtran.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 09:00:00 EET | Press release

Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a wholly owned subsidiary of Radiology Partners, the largest radiology practice in the U.S, with more than 4,000 radiologists in its network. Cognita CXR1 applies a proprietary

SOLUM and Simbe Expand European Collaboration to Advance Intelligent Store Operations5.3.2026 09:00:00 EET | Press release

SOLUM (KOSPI: 248070) and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. The collaboration was highlighted at EuroShop, where Simbe’s Store Intelligence™ platform was demonstrated live at the SOLUM booth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304620371/en/ SOLUM and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. (Image: SOLUM) Simbe recently introduced Tally 4.0, the next generation of their autonomous shelf-scanning robot, reflecting the company’s continued evolution in retail shelf digitization, incorporating extended runtime, enhanced edge computing, and advanced vision capabilities. Designed to deliver deeper shelf coverag

Cielo Advances Resilient Remote Connectivity for Its Nationwide Payment Terminal Fleet With Thales5.3.2026 09:00:00 EET | Press release

For Cielo, connectivity is mission critical. When payment terminals lose network access, transactions stop. To strengthen operational resilience and enhance merchant experience, Cielo is modernizing its connectivity architecture across its terminal fleet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304089321/en/ Cielo advances resilient remote connectivity for its nationwide payment terminal fleet with Thales. Using Thales’s eSIM technology as part of this strategy, Cielo can remotely switch mobile network operators over the air in just a few seconds, without sending a technician and with minimal disruption to merchants’ activity. For merchants, the experience is seamless: if a network becomes unstable, the payment terminal can automatically reconnect to another available network, often without the merchant even noticing. This deployment represents one of the first large-scale implementations of the SGP.32 eSIM specifi

GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.5.3.2026 09:00:00 EET | Press release

GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic partnership to commercialize lipodia upon regulatory approval1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224658973/en/ Dr. Mario Weiss, Founder & CEO of GAIA AG This digital therapeutic is designed to support adults living with hypercholesterolemia. The comprehensive collaboration brings together GAIA’s long-standing expertise in developing clinically validated non-pharmacological interventions with Daiichi Sankyo’s highly scientific experience in cardiovascular risk management and health. Together, the partners - both members of the German Association of Research-Based Pharmaceutical Companies (vfa) - aim to address a persistent gap in chronic care: leveraging digital technologies to make a difference in patients’ lives by supporting sustainable, long-term behaviour change. Expanding Cardiovasc

Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency 1 , and Core EBITDA 2 of 1.211 billion USD, Growing 18.9% at Constant Currency5.3.2026 08:00:00 EET | Press release

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025. Record net sales of 5,207 million USD, surpassing 5 billion USD in a year for the first time and representing 17.7% year-on-year growth on a constant currency1 basis, primarily driven by volume. Broad-based net sales growth, growing double-digits in both International markets and the U.S. Outperforming the market in each product category, with strong net sales growth in Injectable Aesthetics (11.5%), Dermatological Skincare (9.3%) and Therapeutic Dermatology (50.2%), all year-on-year at constant currency. Strong launch momentum across future growth drivers, including Nemluvio® (nemolizumab) delivering 452 million USD in net sales; Relfydess™ (RelabotulinumtoxinA) outperforming expectations in 17 International markets; Sculptra® gaining significant market share in its first year in China; and continued new product launches across Galderma’s full portfoli

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye